BACKGROUND AND PURPOSE: Ischemic stroke provokes a systemic inflammatory response. The purpose of this study was to characterize this response on the gene expression level in circulating mononuclear leukocytes from acute ischemic stroke (AIS) patients. METHODS: RNA from peripheral blood mononuclear cells (PBMCs) of AIS patients (24 + 2 hours after onset of symptoms) was analyzed with Affymetrix U133A GeneChips using a pooled design. We compared the gene expression signature from AIS patients (n = 20), stroke survivors (n = 15), patients with acute traumatic brain injury (ATBI, n = 15) and healthy control subjects without vascular risk factors (n = 15). RESULTS: Expression levels of 9682 probe sets with present calls on each GeneChip were compared. Between AIS patients and stroke survivors or between AIS patients and ATBI patients there were no significant differences in expression values of single genes after correction for multiple testing. However, comparison of the PBMC expression profiles from AIS patients and healthy subjects revealed significantly different expression (p = 0.012) of a single probe set, specific for phosphodiesterase 4 D (PDE4D). In order to detect modest expression differences in multiple genes with a presumed cumulative effect we studied the gene expression of functional groups of genes by global statistical tests. Analysis of 11 gene groups revealed differential expression between AIS patients and healthy subjects for genes involved in the inflammatory response (GeneOntology GO:0006954). Genes encoding the N-formyl peptide receptor-like 1 (FPRL1), interleukin-1 receptor antagonist (IL1RN) and complement component 3a receptor 1 (C3AR1) contributed most to the observed difference. CONCLUSIONS: This transcriptome analysis did not identify significant changes between circulating mononuclear cells from AIS patients 24 hours after stroke and closely matched stroke survivors. However, comparing AIS patients with healthy control subjects revealed measurable differences in PDE4D and in inflammatory response genes when considered as a set.
BACKGROUND AND PURPOSE:Ischemic stroke provokes a systemic inflammatory response. The purpose of this study was to characterize this response on the gene expression level in circulating mononuclear leukocytes from acute ischemic stroke (AIS) patients. METHODS: RNA from peripheral blood mononuclear cells (PBMCs) of AISpatients (24 + 2 hours after onset of symptoms) was analyzed with Affymetrix U133A GeneChips using a pooled design. We compared the gene expression signature from AISpatients (n = 20), stroke survivors (n = 15), patients with acute traumatic brain injury (ATBI, n = 15) and healthy control subjects without vascular risk factors (n = 15). RESULTS: Expression levels of 9682 probe sets with present calls on each GeneChip were compared. Between AISpatients and stroke survivors or between AISpatients and ATBI patients there were no significant differences in expression values of single genes after correction for multiple testing. However, comparison of the PBMC expression profiles from AISpatients and healthy subjects revealed significantly different expression (p = 0.012) of a single probe set, specific for phosphodiesterase 4 D (PDE4D). In order to detect modest expression differences in multiple genes with a presumed cumulative effect we studied the gene expression of functional groups of genes by global statistical tests. Analysis of 11 gene groups revealed differential expression between AISpatients and healthy subjects for genes involved in the inflammatory response (GeneOntology GO:0006954). Genes encoding the N-formyl peptide receptor-like 1 (FPRL1), interleukin-1 receptor antagonist (IL1RN) and complement component 3a receptor 1 (C3AR1) contributed most to the observed difference. CONCLUSIONS: This transcriptome analysis did not identify significant changes between circulating mononuclear cells from AISpatients 24 hours after stroke and closely matched stroke survivors. However, comparing AISpatients with healthy control subjects revealed measurable differences in PDE4D and in inflammatory response genes when considered as a set.
Authors: Y V Subrahmanyam; S Yamaga; Y Prashar; H H Lee; N P Hoe; Y Kluger; M Gerstein; J D Goguen; P E Newburger; S M Weissman Journal: Blood Date: 2001-04-15 Impact factor: 22.113
Authors: Paola Sebastiani; Marco F Ramoni; Vikki Nolan; Clinton T Baldwin; Martin H Steinberg Journal: Nat Genet Date: 2005-03-20 Impact factor: 38.330
Authors: Robert A Jolly; Keith M Goldstein; Tao Wei; Hong Gao; Peining Chen; Shuguang Huang; Jean-Marie Colet; Timothy P Ryan; Craig E Thomas; Shawn T Estrem Journal: Physiol Genomics Date: 2005-05-24 Impact factor: 3.107
Authors: Nan Chiang; Charles N Serhan; Sven-Erik Dahlén; Jeffrey M Drazen; Douglas W P Hay; G Enrico Rovati; Takao Shimizu; Takehiko Yokomizo; Charles Brink Journal: Pharmacol Rev Date: 2006-09 Impact factor: 25.468
Authors: Scott R Barnum; Robert S Ames; Peter R Maycox; Sarah J Hadingham; Jackie Meakin; David Harrison; Andrew A Parsons Journal: Glia Date: 2002-04-15 Impact factor: 7.452
Authors: Kenneth C Malcolm; Patrick G Arndt; Elizabeth J Manos; David A Jones; G Scott Worthen Journal: Am J Physiol Lung Cell Mol Physiol Date: 2002-12-20 Impact factor: 5.464
Authors: Bradford B Worrall; Thomas G Brott; Robert D Brown; W Mark Brown; Stephen S Rich; Sampath Arepalli; Fabienne Wavrant-De Vrièze; Jaime Duckworth; Andrew B Singleton; John Hardy; James F Meschia Journal: Stroke Date: 2007-03-01 Impact factor: 7.914
Authors: Stanislav O Zakharkin; Kyoungmi Kim; Tapan Mehta; Lang Chen; Stephen Barnes; Katherine E Scheirer; Rudolph S Parrish; David B Allison; Grier P Page Journal: BMC Bioinformatics Date: 2005-08-29 Impact factor: 3.169
Authors: H C A Emsley; C J Smith; R F Georgiou; A Vail; S J Hopkins; N J Rothwell; P J Tyrrell Journal: J Neurol Neurosurg Psychiatry Date: 2005-10 Impact factor: 10.154
Authors: Whitney S Livingston; Jessica M Gill; Martin R Cota; Anlys Olivera; Jessica L O'Keefe; Christiana Martin; Lawrence L Latour Journal: J Neurotrauma Date: 2016-08-30 Impact factor: 5.269
Authors: Anthony A Oliva; Yuan Kang; Concepcion Furones; Ofelia F Alonso; Olga Bruno; W Dalton Dietrich; Coleen M Atkins Journal: J Neurochem Date: 2012-11-01 Impact factor: 5.372
Authors: Mateusz G Adamski; Yan Li; Erin Wagner; Hua Yu; Chloe Seales-Bailey; Steven A Soper; Michael Murphy; Alison E Baird Journal: Genomics Date: 2014-08-15 Impact factor: 5.736
Authors: Feng Shen; Bing Sun; Jason E Kreutz; Elena K Davydova; Wenbin Du; Poluru L Reddy; Loren J Joseph; Rustem F Ismagilov Journal: J Am Chem Soc Date: 2011-10-13 Impact factor: 15.419
Authors: Sadani N Cooray; Thomas Gobbetti; Trinidad Montero-Melendez; Simon McArthur; Dawn Thompson; Adrian J L Clark; Roderick J Flower; Mauro Perretti Journal: Proc Natl Acad Sci U S A Date: 2013-10-09 Impact factor: 11.205